Search results
Results from the WOW.Com Content Network
The Drug Abuse Warning Network (DAWN) and National Household Survey on Drug Abuse (NHSDA) were created in 1972. In 1974 NIDA was established as part of the Alcohol, Drug Abuse, and Mental Health Administration and given authority over the DAWN and NHSDA programs.
In the late 1990s, Huestis started one of the few human clinical research labs in the world to test illicit drugs in humans. In 1998, she became chief of the chemistry and drug metabolism section of the NIDA. [2] She retired in 2016 after 23 years at NIDA. Huestis was an adjunct professor at the University of Maryland School of Medicine. [3]
NAHDAP's staff consists of professional researchers, data archivists and technicians working together to obtain, process, distribute, and promote amongst social science researchers sharing of data relevant to drug addiction and HIV. NAHDAP is a project of the National Institute on Drug Abuse, part of the National Institutes of Health.
Typhoon Nida (disambiguation) National Institute of Development Administration, a graduate university in Bangkok, Thailand; National Institute of Dramatic Art, Sydney, Australia; National Institute on Drug Abuse, a branch of the National Institutes of Health in the United States; National Internet Development Agency of Korea
Wilson M. Compton is the deputy director of the National Institute on Drug Abuse (NIDA). Before being appointed to this position in 2013, he was the director of the NIDA's Division of Epidemiology, Services and Prevention Research since 2002. He has also served as a member of the DSM-5 Task Force and the Substance Use Disorders Workgroup.
Jean Lud Cadet is a Haitian-American psychiatrist at the National Institute on Drug Abuse (NIDA), where he serves as National Institutes of Health Chief of the Molecular Neuropsychiatry Research Branch. His research considers the genetic, epigenetic and cellular bases of substance abuse.
One of the scientific institutes of the U.S. National Institutes of Health, NIDA supports over 85 percent of the world's research on the health aspects of drug abuse and addiction. Before becoming director of NIDA, Leshner was the deputy director and acting director of the National Institute of Mental Health.
Prescription drug overuse or non-medical prescription drug use is the use of prescription medications that is more than the prescribed amount, regardless of whether the original medical reason to take the drug is legitimate. [1] [2] A prescription drug is a drug substance prescribed by a doctor and intended to for individual use only. [3]